These findings suggest that CD164 may play a multifaceted role in immune regulation, potentially reducing immunosuppression through Tregs while also influencing the composition and function of other immune cell populations, including M0 macrophages and NK cells, within the tumor microenvironment. This evidence concerns the gene CD164 and neoplasm.